Table 9.
Hematologic values of polo horses with glanders during the study period
|
Treatment period (n = 23) |
Post treatment observation period (n = 17) |
||||
|---|---|---|---|---|---|
| Parameters | d 0 | d 84 | d 180 | d 240 | d 360 |
|
RBC count (1012/1) |
3.94 ± 0.78 |
6.30 ± 0.4 |
6.80 ± 0.37 |
7.053 ± 0.29 |
6.957 ± 0.36 |
|
WBC count (109/1) |
19.15 ± 4.11 |
8.10 ± 0.79 |
7.91 ± 1.23 |
7.97 ± 2.14 |
7.52 ± 1.12 |
|
Hb [g/dL] |
7.918 ± 1.7 |
11.94 ± 0.69 |
12.79 ± 1.1 |
13.58 ± 1.0 |
13.13 ± 1.2 |
|
PCV (ratio) |
0.25 ± 0.047 |
0.38 ± 0.015 |
0.41 ± 0.028 |
0.39 ± 0.025 |
0.38 ± 0.0 12 |
|
ESR (mm/20 min) |
126.83 ± 10.40 |
25.15 ± 2.6 |
21.42 ± 1.94 |
23.19 ± 2.41 |
19.89 ± 3.15 |
|
Differential Leukocyte Count |
|
||||
|
Neutrophils (%) |
73.06 ± 9.12 |
51.0 ± 9.12 |
50.3 ± 4.39 |
53.2 ± 3.14 |
57.28 ± 0.89 |
|
Lymphocytes (%) |
21.69 ± 6.95 |
39.7 ± 3.91 |
47.1 ± 3.01 |
43.01 ± 2.10 |
37.5 ± 1.23 |
|
Eosinophils (%) |
4.77 ± 2.16 |
3.11 ± 0.57 |
2.12 ± 0.76 |
2.190 ± 0.911 |
4.23 ± 2.11 |
|
Monocytes (%) |
1.69 ± 1.02 |
1.52 ± 0.89 |
1.76 ± 1.40 |
2.140 ± 1.024 |
1.2 ± 1.00 |
| Basophils (%) | - | - | - | - | - |